We had a real solid lead on everyone up until last summer.. already got through HIV trials and demonstrated safety, proved safety in Covid with CD10.. plus CD12, eIND and OLE data, there should be enough for an EUA and P4 looking at dosing, administration, etc. But they want a tighter P3... It needs to get going ASAP. Maybe it's semantics.. I think we just lost the lead, timewise. Administration, storage, efficacy are still way out in front.